MLTX vs. QQQ

In the year-to-date period, MLTX achieves a -28.96% return, which is significantly lower than QQQ's -4.41% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for MoonLake Immunotherapeutics (MLTX) and Invesco QQQ (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current MLTX Sharpe Ratio is -0.17, which is lower than the QQQ Sharpe Ratio of 0.45. The chart below compares the historical Sharpe Ratios of MLTX and QQQ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

MLTX has not paid dividends to shareholders, while QQQ's dividend yield for the trailing twelve months is around 0.61%.

The maximum MLTX drawdown since its inception was -64.60%, smaller than the maximum QQQ drawdown of -82.98%. Use the drawdown chart below to compare losses from any high point for MLTX and QQQ. For additional features, visit the drawdowns tool.

MoonLake Immunotherapeutics (MLTX) has a higher volatility of 15.34% compared to Invesco QQQ (QQQ) at 8.24%. This indicates that MLTX's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.